Progesterone increases nitric oxide synthesis in human vascular endothelial cells through activation of membrane progesterone receptor-α

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 10, 2015, Pages E899-E911

  Pang, Yefei ^a   Dong, Jing ^a   Thomas, Peter ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Human vascular endothelial cells; Membrane progesterone receptors; Nitric oxide; Nitric oxide synthase; Rapid progesterone action

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MEDROXYPROGESTERONE ACETATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR ALPHA; PROMEGESTONE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; NOS3 PROTEIN, HUMAN; PROGESTERONE RECEPTOR A; PROTEIN SERINE THREONINE KINASE;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SYNTHESIS; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR TISSUE; WESTERN BLOTTING; AGONISTS; BIOSYNTHESIS; BLOOD VESSEL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; FEMALE; METABOLISM; PHOSPHORYLATION; PLACENTA; PREGNANCY;

BLOOD VESSELS; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PLACENTA; PREGNANCY; PROGESTERONE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, PROGESTERONE;

EID: 84930833064     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00527.2014     Document Type: Article

References (74)

1. Ahmed IS, Rohe HJ, Twist KE, Craven RJ. Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. J Biol Chem 285: 24775–24782, 2010.
2. Barbagallo M, Dominguez LJ, Licata G, Shan J, Bing L, Karpinski E, Pang PK, Resnick LM. Vascular effects of progesterone: role of cellular calcium regulation. Hypertension 37: 142–147, 2001.
3. Boonyaratanakornkit V, Bi Y, Rudd M, Edwards DP. The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression. Steroids 73: 922–928, 2008.
4. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8: 269–280, 2001.
5. Bottino MC, Cerliani JP, Rojas P, Giulianelli S, Soldati R, Mondillo C, Gorostiaga MA, Pignataro OP, Calvo JC, Gutkind JS, Panomwat A, Molinolo AA, Luthy IA, Lanari C. Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects. Breast Cancer Res Treat 126: 621–636, 2011.
6. Brost BC, Newman RB, Hendricks SK, Droste S, Mathur RS. Effect of hemodialysis on serum progesterone level in pregnant women. Am J Kidney Dis 33: 917–919, 1999.
7. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23: 665–686, 2002.
8. Cheng M, Zhang W, Chen H, Wu W, Huang H. DNA microarray reveals changes in gene expression of endothelial cells under shear stress. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21: 188–192, 2004.
9. Chow RW, Handelsman DJ, Ng MK. Minireview: rapid actions of sex steroids in the endothelium. Endocrinology 151: 2411–2422, 2010.
10. Dosiou C, Hamilton AE, Pang Y, Overgaard MT, Tulac S, Dong J, Thomas P, Giudice LC. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol 196: 67–77, 2008.
11. Dressing GE, Alyea R, Pang Y, Thomas P. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm Cancer 3: 101–112, 2012.
12. Dressing GE, Goldberg JE, Charles NJ, Schwertfeger KL, Lange CA. Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications. Steroids 76: 11–17, 2010.
13. Dressing GE, Pang Y, Dong J, Thomas P. Progestin signaling through mPRalpha in Atlantic croaker granulosa/theca cell cocultures and its involvement in progestin inhibition of apoptosis. Endocrinology 151: 5916–5926, 2010.
14. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 32: 730–734, 1998.
15. Fu XD, Flamini M, Sanchez AM, Goglia L, Giretti MS, Genazzani AR, Simoncini T. Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod 14: 225–234, 2008.
16. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288: 49–57, 2002.
17. Hansson GK, Geng YJ, Holm J, Hårdhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 180: 733–738, 1994.
18. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677–682, 2000.
19. Hermsmeyer RK, Mishra RG, Pavcnik D, Uchida B, Axthelm MK, Stanczyk FZ, Burry KA, Illingworth DR, Juan C, Nordt FJ. Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone. Arterioscler Thromb Vasc Biol 24: 955–961, 2004.
20. Hermsmeyer RK, Thompson TL, Pohost GM, Kaski JC. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? Nat Clin Pract Cardiovasc Med 5: 387–395, 2008.
21. Jazbutyte V, Arias-Loza PA, Hu K, Widder J, Govindaraj V, von Poser-Klein C, Bauersachs J, Fritzemeier KH, Hegele-Hartung C, Neyses L, Ertl G, Pelzer T. Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res 77: 774–781, 2008.
22. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85: 447–452, 1976.
23. Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, Thomas P. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 20: 1519–1534, 2006.
24. Kelder J, Azevedo R, Pang Y, de Vlieg J, Dong J, Thomas P. Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPR alpha-specific agonists. Steroids 75: 314–322, 2010.
25. Khorram O, Han G. Influence of progesterone on endometrial nitric oxide synthase expression. Fertil Steril 91: 2157–2162, 2009.
26. Landau RL, Bergenstal DM, Lugibihl K, Kascht ME. The metabolic effects of progesterone in man. J Clin Endocrinol Metab 15: 1194–1215, 1955.
27. Levenson JW, Skerrett PJ, Gaziano JM. Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol 5: 188–199, 2002.
28. Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 285: H2188–H2193, 2003.
29. Luisi S, Petraglia F, Benedetto C, Nappi RE, Bernardi F, Fadalti M, Reis FM, Luisi M, Genazzani AR. Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 85: 2429–2433, 2000.
30. MacGillivray I, Rose GA, Rowe B. Blood pressure survey in pregnancy. Clin Sci 37: 395–407, 1969.
31. McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu CM, Russell CG, Chittur KK. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 98: 8955–8960, 2001.
32. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90: 3F–6F, 2002.
33. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583–1587, 2005.
34. Minshall RD, Pavcnik D, Browne DL, Hermsmeyer K. Nongenomic vasodilator action of progesterone on primate coronary arteries. J Appl Physiol 92: 701–708, 2002.
35. Nath A, Sitruk-Ware R. Different cardiovascular effects of progestins according to structure and activity. Climacteric 12, Suppl 1: 96–101, 2009.
36. Ndiaye K, Poole DH, Walusimbi S, Cannon MJ, Toyokawa K, Maalouf SW, Dong J, Thomas P, Pate JL. Progesterone effects on lymphocytes may be mediated by membrane progesterone receptors. J Reprod Immunol 95: 15–26, 2012.
37. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76: 536–543, 1995.
38. Nutu M, Weijdegard B, Thomas P, Bergh C, Thurin-Kjellberg A, Pang Y, Billig H, Larsson DG. Membrane progesterone receptor gamma: tissue distribution and expression in ciliated cells in the fallopian tube. Mol Reprod Dev 74: 843–850, 2007.
39. Ohura N, Yamamoto K, Ichioka S, Sokabe T, Nakatsuka H, Baba A, Shibata M, Nakatsuka T, Harii K, Wada Y, Kohro T, Kodama T, Ando J. Global analysis of shear stress-responsive genes in vascular endothelial cells. J Atheroscler Thromb 10: 304–313, 2003.
40. Omar HA, Ramirez R, Gibson M. Properties of a progesterone-induced relaxation in human placental arteries and veins. J Clin Endocrinol Metab 80: 370–373, 1995.
41. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233–R249, 2004.
42. Pace MC, Thomas P. Steroid-induced oocyte maturation in Atlantic croaker (Micropogonias undulatus) is dependent on activation of the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Biol Reprod 73: 988–996, 2005.
43. Pang Y, Dong J, Thomas P. Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors delta and epsilon (mPRdelta and mPRepsilon) and mPRdelta involvement in neurosteroid inhibition of apoptosis. Endocrinology 154: 283–295, 2013.
44. Pang Y, Thomas P. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor. Steroids 76: 921–928, 2011.
45. Pecins-Thompson M, Keller-Wood M. Effects of progesterone on blood pressure, plasma volume, and responses to hypotension. Am J Physiol Regul Integr Comp Physiol 272: R377–R385, 1997.
46. Ramirez RJ, Gibson M, Kalenic J, Einzig S, Omar HA. In vitro vascular relaxation to progesterone and its metabolites in human umbilical and placental blood vessels. J Matern Fetal Investig 8: 61–65, 1998.
47. Reckelhoff JF. Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension 45: 170–174, 2005.
48. Regensteiner JG, Hiatt WR, Byyny RL, Pickett CK, Woodard WD, Moore LG. Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women. J Clin Pharmacol 31: 543–548, 1991.
49. Roesch DM, Keller-Wood M. Progesterone rapidly reduces arterial pressure in ewes. Am J Physiol Heart Circ Physiol 272: H386–H391, 1997.
50. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333, 2002.
51. Rylance PB, Brincat M, Lafferty K, De Trafford JC, Brincat S, Parsons V, Studd JW. Natural progesterone and antihypertensive action. Br Med J (Clin Res Ed) 290: 13–14, 1985.
52. Selles J, Polini N, Alvarez C, Massheimer V. Nongenomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell Signal 14: 431–436, 2002.
53. Selles J, Polini N, Alvarez C, Massheimer V. Progesterone and 17 beta-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci 69: 815–827, 2001.
54. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A, Genazzani AR, Petraglia F. Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 84: 2802–2806, 1999.
55. Simoncini T, Caruso A, Giretti MS, Scorticati C, Fu XD, Garibaldi S, Baldacci C, Mannella P, Fornari L, Genazzani AR. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril 86: 1235–1242, 2006.
56. Simoncini T, Mannella P, Fornari L, Caruso A, Willis MY, Garibaldi S, Baldacci C, Genazzani AR. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145: 5745–5756, 2004.
57. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144: 3449–3455, 2003.
58. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids 65: 651–658, 2000.
59. Sleiter N, Pang Y, Park C, Horton TH, Dong J, Thomas P, Levine JE. Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release. Endocrinology 150: 3833–3844, 2009.
60. Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 34: 171–208, 2013.
61. Tang YT, Hu T, Arterburn M, Boyle B, Bright JM, Emtage PC, Funk WD. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol 61: 372–380, 2005.
62. Tatsumi H, Kitawaki J, Tanaka K, Hosoda T, Honjo H. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 42: 287–294, 2002.
63. Thomas P, Pang Y. Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects. Steroids 78: 583–588, 2013.
64. Thomas P, Pang Y, Dong J. Enhancement of cell surface expression and receptor functions of membrane progestin receptor alpha (mPRalpha) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors. Endocrinology 155: 1107–1119, 2014.
65. Thomas P, Pang Y, Dong J, Groenen P, Kelder J, de Vlieg J, Zhu Y, Tubbs C. Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology 148: 705–718, 2007.
66. Thomas P, Pang Y, Zhu Y, Detweiler C, Doughty K. Multiple rapid progestin actions and progestin membrane receptor subtypes in fish. Steroids 69: 567–573, 2004.
67. Toth B, Saadat G, Geller A, Scholz C, Schulze S, Friese K, Jeschke U. Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor A (PR-A), but not ERalpha and PR-B. Histochem Cell Biol 130: 399–405, 2008.
68. Tubbs C, Thomas P. Progestin signaling through an olfactory G protein and membrane progestin receptor-alpha in Atlantic croaker sperm: potential role in induction of sperm hypermotility. Endocrinology 150: 473–484, 2009.
69. Welter BH, Hansen EL, Saner KJ, Wei Y, Price TM. Membrane-bound progesterone receptor expression in human aortic endothelial cells. J Histochem Cytochem 51: 1049–1055, 2003.
70. Wiinberg N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, Svendsen TL, Kampmann JP, Madsen NH, Bentzon MW. 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 8: 978–986, 1995.
71. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, Papera S, Sealey JE, Laragh JH. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 68: 97–104, 1980.
72. You S, Zuo L, Varma V. Broad tissue expression of membrane progesterone receptor alpha in normal mice. J Mol Histol 41: 101–110, 2010.
73. Zhang Y, Janssens SP, Wingler K, Schmidt HH, Moens AL. Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy. Am J Physiol Heart Circ Physiol 301: H634–H646, 2011.
74. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100: 2231–2236, 2003.